Eris Lifesciences Ltd approved the limited reviewed unaudited financial results for the quarter and nine months ended December 31, 2023, and also announced the acquisition of a 51% equity stake in Swiss Parenterals Limited.
AI Assistant
ERIS Lifesciences Ltd
2024
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.